Un-blinding, Pharmacovigilance Issues Among Top GCP Findings, Says UK Inspector
Executive Summary
A UK good clinical practice inspector discusses common findings issued in relation to clinical trials as well as the challenges posed by new technologies, such as use of apps on smartphones and electronic patient diaries to record outcomes.
You may also be interested in...
EMA Clarifies Sponsor's Role In Validating Electronic Systems Used In Clinical Trials
The European Medicines Agency has issued guidance in response to a growing number of queries from sponsors on how they should qualify/validate the electronic systems they use in a clinical trial setting when the systems have already been qualified by a vendor. The issue has already resulted in deviations being issued during good clinical practice inspections.
Revised EU Guide Addresses Ambiguities In Reporting of Safety Info From Trials
The pharmaceutical industry is hoping that changes to the EU guideline on the management and presentation of reference safety information (RSI) in clinical trial applications will help companies struggling with new regulatory focus on this complex subject.
UK MHRA Takes Companies To Task Over Trial Safety Information Reporting
Sponsors of clinical trials in the EU have recently been inundated with objections from regulators for incorrectly managing their clinical trial reference safety information, which in turn has resulted in these trials being significantly delayed. A UK MHRA inspector discusses some of the common issues identified during inspections on this front.